Moderna (NASDAQ: MRNA) net income
Moderna reported a net loss of $2,822m for fiscal 2025; in fiscal 2024 it reported a net loss of $3,561m. Earnings per share were −$7.26.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$2,822m | — | −145.2% | −$7.26 |
| 2024 | −$3,561m | — | −110.0% | −$9.28 |
| 2023 | −$4,714m | −156.4% | −68.8% | −$12.33 |
| 2022 | $8,362m | −31.5% | 43.4% | $21.26 |
| 2021 | $12,202m | — | 66.1% | $30.31 |
| 2020 | −$747.0m | — | −93.0% | −$1.96 |
| 2019 | −$514.0m | — | −856.7% | −$1.55 |
| 2018 | −$384.7m | — | −284.8% | — |
| 2017 | −$255.9m | — | −124.3% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Moderna
- How much did Moderna earn in fiscal 2025?
- Moderna reported a net loss of $2,822m for fiscal 2025. In fiscal 2024 it reported a net loss of $3,561m.
- What are the earnings per share of Moderna?
- They were −$7.26 in fiscal 2025, compared with −$9.28 in fiscal 2024.
- What was the most profitable year for Moderna?
- Of its last 9 fiscal years, fiscal 2021, with $12,202m.
- Where do the figures for Moderna come from?
- From the annual report (Form 10-K) that Moderna files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Moderna files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Moderna: the Moderna page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.